Literature DB >> 20018318

Multivariate analysis of risk factors for long-term urethroplasty outcome.

Benjamin N Breyer1, Jack W McAninch, Jared M Whitson, Michael L Eisenberg, Jennifer F Mehdizadeh, Jeremy B Myers, Bryan B Voelzke.   

Abstract

PURPOSE: We studied the patient risk factors that promote urethroplasty failure.
MATERIALS AND METHODS: Records of patients who underwent urethroplasty at the University of California, San Francisco Medical Center between 1995 and 2004 were reviewed. Cox proportional hazards regression analysis was used to identify multivariate predictors of urethroplasty outcome.
RESULTS: Between 1995 and 2004, 443 patients of 495 who underwent urethroplasty had complete comorbidity data and were included in analysis. Median patient age was 41 years (range 18 to 90). Median followup was 5.8 years (range 1 month to 10 years). Stricture recurred in 93 patients (21%). Primary estimated stricture-free survival at 1, 3 and 5 years was 88%, 82% and 79%. After multivariate analysis smoking (HR 1.8, 95% CI 1.0-3.1, p = 0.05), prior direct vision internal urethrotomy (HR 1.7, 95% CI 1.0-3.0, p = 0.04) and prior urethroplasty (HR 1.8, 95% CI 1.1-3.1, p = 0.03) were predictive of treatment failure. On multivariate analysis diabetes mellitus showed a trend toward prediction of urethroplasty failure (HR 2.0, 95% CI 0.8-4.9, p = 0.14).
CONCLUSIONS: Length of urethral stricture (greater than 4 cm), prior urethroplasty and failed endoscopic therapy are predictive of failure after urethroplasty. Smoking and diabetes mellitus also may predict failure potentially secondary to microvascular damage. Copyright 2010 American Urological Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20018318     DOI: 10.1016/j.juro.2009.10.018

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  65 in total

1.  A report on the clinical efficacy of a new Bougie-internal urethrectomy.

Authors:  Choe Sung Hyn; Kim Han Jong; Choe Un Chol
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  National Variation in Urethroplasty Cost and Predictors of Extreme Cost: A Cost Analysis With Policy Implications.

Authors:  Catherine R Harris; E Charles Osterberg; Thomas Sanford; Amjad Alwaal; Thomas W Gaither; Jack W McAninch; Charles E McCulloch; Benjamin N Breyer
Journal:  Urology       Date:  2016-04-20       Impact factor: 2.649

Review 3.  [Urethral stricture : From diagnostics to appropriate treatment].

Authors:  F Strittmatter; V Beck; C G Stief; S Tritschler
Journal:  Urologe A       Date:  2017-08       Impact factor: 0.639

4.  Direct visual internal urethrotomy for isolated, post-urethroplasty strictures: a retrospective analysis.

Authors:  Elizabeth Timbrook Brown; Stephen Mock; Roger Dmochowski; W Stuart Reynolds; Douglas Milam; Melissa R Kaufman
Journal:  Ther Adv Urol       Date:  2016-12-02

Review 5.  Urethral stricture: etiology, investigation and treatments.

Authors:  Stefan Tritschler; Alexander Roosen; Claudius Füllhase; Christian G Stief; Herbert Rübben
Journal:  Dtsch Arztebl Int       Date:  2013-03-29       Impact factor: 5.594

6.  [Sachse internal urethrotomy: endoscopic treatment of urethral strictures].

Authors:  D Pfalzgraf; A Häcker
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

7.  [Management of urethral strictures: practical guidelines].

Authors:  S Tritschler; C Füllhase; C Stief; A Roosen
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

8.  [Urethral strictures: a difficult path to standardized and simultaneously individualized therapy].

Authors:  S Tritschler; C G Stief
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

9.  The UREThRAL stricture score: A novel method for describing anterior urethral strictures.

Authors:  Lucas R Wiegand; Steven B Brandes
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

Review 10.  Graft surgery in extensive urethral stricture disease.

Authors:  Miroslav L Djordjevic
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.